Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How to Deliver Difficult News about Patients’ Diagnoses

Karen Appold  |  Issue: July 2015  |  July 14, 2015

David Borenstein, MD, MACR, MACP, partner, Arthritis and Rheumatism Associates, and clinical professor, Medicine Division of Rheumatology, Department of Medicine, The George Washington University Medical Center, Washington, D.C., begins by saying that he has formed his opinion by reviewing the patient’s medical history, laboratory studies and radiographs, and by completing a physical examination. “Patients realize that I have spent the time to arrive at a conclusion that is based on what pertains to his or her situation at the present time,” he says. “I may agree with what may have been given as a diagnosis previously or tell the patient why I have formed a different conclusion. If this is a new diagnosis, I assure the patient that I will provide the reasons for my diagnosis.”

Nuts & Bolts

When relaying negative news, it’s helpful to share information in small quantities and to pause frequently. “This allows you to assess the patient’s understanding of what you said and gauge his or her emotional response to the information,” Dr. Kim says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Part of communicating bad news is also giving the patient the space and time to respond to it. Initially after hearing the bad news, the patient may be angry, confused or distressed. You should allow the patient to go through this phase by waiting quietly. When the patient is ready to talk, you can respond with empathetic statements, such as, ‘I can only imagine what you’re going through right now,’ or ‘this must be overwhelming for you.’”

Sometimes, visuals can be helpful. If you think drawing a diagram is the best way for the patient to understand what you are saying, say, “I think it would be helpful to explain it this way,” and then offer the diagram. “Looking at something, rather than just listening, is a different way to take in information, which some patients really welcome,” Dr. Minardo says. Handouts and pamphlets can be helpful as well.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

When sharing information about the diagnosis, it can also be important to discuss the prognosis. Regarding RA, Dr. Kim might say, “I do have some good news. In the past couple of decades, many new medicines for RA have come onto the market. RA is actually a very treatable condition. I want you to feel hopeful about this disease, because we can control it with medications and prevent future damage and deformities in your hands.”

Likewise, Dr. Borenstein tries to reassure patients that the medical community’s abilities to care for individuals with osteoarthritis, RA and other rheumatic diseases have advanced significantly in recent years. “I tell patients that therapy will correspond to the intensity of disease and the patient’s response,” he says. “I will begin by prescribing therapies with fewer toxicities, and only advance to medications with more side effects if necessary. I also point out that non-drug therapies, such as physical therapy, certain forms of exercise and good nutritional choices, can have beneficial effects.”

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:chronic conditionDiagnosispatient carephysicianrheumatologist

Related Articles

    Never Give Up on a Patient

    May 16, 2011

    ACR President David Borenstein, MD, receives AF honor for his dedication to rheumatology

    ACR 2013 State-of-the-Art Clinical Symposium: The Challenge of Treating Low Back Pain

    August 1, 2013

    With no single therapy effective for chronic low back pain, physicians must try multiple therapeutic approaches, nonsurgical options

    alphaspirit/shutterstock.com

    Create a Physician Website that Conveys Authority, Expertise

    August 18, 2015

    A website provides visitors with a first glimpse of your practice. “Whether you like it or not, people will learn about you and judge you based on your website,” says David Borenstein, MD, MACR, MACP, rheumatologist and partner, Arthritis and Rheumatism Associates, and clinical professor of medicine, Division of Rheumatology, Department of Medicine, The George…

    It Takes All Kinds

    July 12, 2011

    A look at the rheumatology practice team

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences